Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Halozyme Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Sutro Biopharma Inc. June 5, 202685.7%
-
Artelo Biosciences Inc. January 30, 202666.3%
-
Artelo Biosciences Inc. June 30, 202387.7%
-
Sutro Biopharma Inc. June 8, 202359.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2025 | Sutro Biopharma Inc. | Open-market purchase | +50,000 | $0.80 | $40,000 |
| Nov 29, 2024 | Halozyme Therapeutics Inc. | Gift | −10,470 | — | — |
| Apr 25, 2024 | Halozyme Therapeutics Inc. | Grant or award | +6,501 | — | — |
| May 5, 2023 | Halozyme Therapeutics Inc. | Grant or award | +8,065 | — | — |
Questions about Connie Matsui
What boards is Connie Matsui on?
Connie Matsui sits on the boards of Artelo Biosciences Inc., Halozyme Therapeutics Inc. and Sutro Biopharma Inc.
How long has Connie Matsui served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.